Cervomed Inc (CRVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,236 | 9,000 | 7,793 | 4,094 | 37,314 |
| Marketable Securities | 12,629 | 29,923 | N/A | N/A | N/A |
| Receivables | 427 | 2,254 | 915 | N/A | N/A |
| Other current assets | 321 | 0 | 0 | 0 | 0 |
| TOTAL | $22,879 | $43,082 | $9,965 | $4,158 | $37,824 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 8 | 0 | 16 |
| TOTAL | $N/A | $N/A | $8 | $N/A | $16 |
| Total Assets | $22,879 | $43,082 | $9,973 | $4,158 | $37,839 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,454 | 1,511 | 663 | 97 | 948 |
| TOTAL | $4,656 | $3,879 | $2,596 | $742 | $2,928 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 12,414 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $12,414 | $N/A |
| Total Liabilities | $4,656 | $3,879 | $2,596 | $13,156 | $2,928 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,259 | 8,703 | 6,170 | 1,360 | 1,359 |
| Common Shares | 9 | 9 | 6 | 1 | 2 |
| Retained earnings | -97,698 | -70,732 | -54,441 | -52,269 | -130,005 |
| Other shareholders' equity | 6 | 56 | 0 | 0 | 0 |
| TOTAL | $18,223 | $39,202 | $7,377 | $-8,998 | $34,912 |
| Total Liabilities And Equity | $22,879 | $43,082 | $9,973 | $4,158 | $37,839 |